Anika announces dismissal of MONOVISC patent infringement suit Anika Therapeutics announced that Genzyme and Anika filed a joint motion with the U.S. District Court for the District of Massachusetts to lift a stay and dismiss a patent infringement lawsuit concerning MONOVISC. MONOVISC received FDA PMA approval in February. The court granted the parties’ motion and issued an order dismissing the litigation with prejudice on March 10. This final and unappealable order resolves the parties’ dispute and is another important milestone toward commercialization of the product in the U.S.
News For ANIK From The Last 14 Days
Check below for free stories on ANIK the last two weeks.